2m 2m 2m 2m 2m 2m 2m
PULMONX (LUNG)
NASDAQ
$1.26-$0.02 (-1.48%)
Price as of Jun 24, 2026 7:59 AM EDT- $54.1MMarket Cap
- -52.50%1-Year Change
- Medical DevicesIndustry
PULMONX (LUNG)
$1.26-$0.02 (-1.48%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
PRIMECAP MANAGEMENT CO/CA/ | 11.19% | 4.7M | -2,800 (-0.06%) | Mar 31, 2026 |
MORGAN STANLEY | 9.46% | 4.0M | -166,907 (-4.18%) | Mar 31, 2026 |
BLACKROCK FUNDING, INC. /DE | 6.75% | 2.9M | +54,593 (+1.92%) | Dec 31, 2024 |
SOLEUS CAPITAL MANAGEMENT, L.P. | 6.60% | 2.8M | +750,000 (+26.90%) | Mar 31, 2026 |
BLACKROCK INC. | 6.32% | 2.7M | -369,500 (-13.85%) | Jun 30, 2024 |
BLACKROCK, INC. | 6.30% | 2.7M | -44,583 (-1.68%) | Mar 31, 2026 |
VANGUARD GROUP INC | 6.01% | 2.5M | +298,348 (+11.74%) | Dec 31, 2025 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
PRIMECAP Odyssey Funds | 8.53% | 3.6M | -32,400 (-0.90%) | Jan 31, 2026 |
VANGUARD INDEX FUNDS | 3.77% | 1.6M | 0 (0.00%) | Mar 31, 2026 |
iSHARES TRUST | 3.29% | 1.4M | -44,025 (-3.17%) | Mar 31, 2026 |
Advisors' Inner Circle Fund II | 2.73% | 1.2M | 0 (0.00%) | Jan 31, 2026 |
FIDELITY ADVISOR SERIES I | 2.47% | 1.0M | 0 (0.00%) | Jan 31, 2026 |
FIDELITY SELECT PORTFOLIOS | 2.27% | 958,751 | 0 (0.00%) | Feb 28, 2026 |
BlackRock Innovation & Growth Trust | 1.68% | 709,937 | 0 (0.00%) | Mar 31, 2026 |
Current Ownership Distribution
- Institutions624.5M (76.31%)
- Mutual Funds187.1M (22.87%)
- Insiders6.7M (0.82%)
- Other0 (0.00%)
Insider Transactions
- 0.82% (6.7M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 6Number of InsiderSelling (last 12 months)
- $16.5MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Radhakrishnan Srikanth Chief Science &Techn. Officer | Sell | Mar 02, 2026 | $1,081.08 | 756 | $1.43 | 180,463 |
Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sell | Mar 02, 2026 | $1,194.05 | 835 | $1.43 | 372,631 |
Radhakrishnan Srikanth Chief Science &Techn. Officer | Sell | Mar 02, 2026 | $4,387.24 | 3,068 | $1.43 | 177,395 |
Lehman David Aaron GENERAL COUNSEL | Sell | Mar 02, 2026 | $1,663.09 | 1,163 | $1.43 | 251,829 |
Radhakrishnan Srikanth Chief Science &Techn. Officer | Sell | Mar 02, 2026 | $3,519.23 | 2,461 | $1.43 | 174,934 |
Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sell | Mar 02, 2026 | $3,038.75 | 2,125 | $1.43 | 370,506 |
Radhakrishnan Srikanth Chief Science &Techn. Officer | Sell | Mar 02, 2026 | $6,003.14 | 4,198 | $1.43 | 170,736 |
French Glendon E. III President and CEO | Sell | Mar 02, 2026 | $3,872.44 | 2,708 | $1.43 | 1.5M |
Radhakrishnan Srikanth Chief Science &Techn. Officer | Award | Mar 02, 2026 | $0.00 | 175,000 | $0.00 | 345,736 |
Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sell | Mar 02, 2026 | $2,661.23 | 1,861 | $1.43 | 368,645 |
Lehman David Aaron GENERAL COUNSEL | Sell | Mar 02, 2026 | $6,339.19 | 4,433 | $1.43 | 247,396 |
Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sell | Mar 02, 2026 | $4,162.73 | 2,911 | $1.43 | 365,734 |
French Glendon E. III President and CEO | Sell | Mar 02, 2026 | $9,633.91 | 6,737 | $1.43 | 1.5M |
Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Award | Mar 02, 2026 | $0.00 | 100,000 | $0.00 | 465,734 |
Lehman David Aaron GENERAL COUNSEL | Sell | Mar 02, 2026 | $3,703.70 | 2,590 | $1.43 | 244,806 |
French Glendon E. III President and CEO | Sell | Mar 02, 2026 | $83,466.24 | 58,368 | $1.43 | 1.4M |
Lehman David Aaron GENERAL COUNSEL | Sell | Mar 02, 2026 | $5,792.93 | 4,051 | $1.43 | 240,755 |
Lehman David Aaron GENERAL COUNSEL | Award | Mar 02, 2026 | $0.00 | 150,000 | $0.00 | 390,755 |
Williamson Steven S. PRESIDENT AND CEO | Sell | Sep 02, 2025 | $8,188.80 | 5,118 | $1.60 | 363,497 |
Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sell | Sep 02, 2025 | $1,131.20 | 707 | $1.60 | 385,624 |
Williamson Steven S. PRESIDENT AND CEO | Sell | Sep 02, 2025 | $7,248.00 | 4,530 | $1.60 | 358,967 |
Joshi Mehul Chief Financial Officer & PAO | Sell | Sep 02, 2025 | $6,833.60 | 4,271 | $1.60 | 212,154 |
Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sell | Sep 02, 2025 | $2,878.40 | 1,799 | $1.60 | 383,825 |
Lehman David Aaron GENERAL COUNSEL | Sell | Sep 02, 2025 | $1,486.40 | 929 | $1.60 | 272,110 |
Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sell | Sep 02, 2025 | $2,520.00 | 1,575 | $1.60 | 382,250 |
Joshi Mehul Chief Financial Officer & PAO | Sell | Sep 02, 2025 | $5,864.00 | 3,665 | $1.60 | 208,489 |
Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sell | Sep 02, 2025 | $3,939.20 | 2,462 | $1.60 | 379,788 |
Lehman David Aaron GENERAL COUNSEL | Sell | Sep 02, 2025 | $5,665.60 | 3,541 | $1.60 | 268,569 |
Lehman David Aaron GENERAL COUNSEL | Sell | Sep 02, 2025 | $3,308.80 | 2,068 | $1.60 | 266,501 |
Lehman David Aaron GENERAL COUNSEL | Sell | Sep 02, 2025 | $5,169.60 | 3,231 | $1.60 | 263,270 |